From: Is there a role for carbohydrate restriction in the treatment and prevention of cancer?
animals | n | tumor | feeding | C/P/F | major fat source | diet initiation | diet duration | BW vs. controls | BG vs. controls | other effects vs. controls | Ref. |
---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | (E%) |  | (d) | (d) |  |  |  |  |
C57BL/6 mice | 18 | B16 melanoma | ad libitum | 0/0/100 1 | PUFA vegetable oil | 0 | 14 | - | ↓ b | lower number of lung metastases b | [116] |
BALB/c mice | 20 | Medina-Oborn-Danielson mammary tumor | restricted to 60 E% of control | 30/60/5 | hydrogenated vegetable oil | ~ 14 | 70 | ↓ | ↓ c | mortality rate ↓ c | [83] |
NMR1 mice | > 15 | MAC16 colon carcinoma | ad libitum | .../.../80 2 | MCT emulsion | 8 | 20 | ↑ | - | 50% less weight loss b; left35% less tumor weight | [121] |
NMR1 mice | ... | MAC16 colon carcinoma | ad libitum | .../.../80 |  | 14 - 21 | 9 | ↑ | - | 36% less weight loss a | [123] |
 |  |  |  |  |  |  |  |  |  | 32% less tumor weight c |  |
 |  |  |  |  |  |  |  |  |  | less nitrogen output a |  |
C57BL/6 mice | 6 | CT-2A mouse astrocytoma | restricted to 60 E% of control | 0/8/92 | lard | 1 | 13 | ↓ 3 | ↓ 3 | 80% less tumor weightb; plasma IGF1 levels ↓ b,3 | [84] |
C57BL/6 mice | 11 | CT-2A mouse astrocytoma | ad libitum | 3/17/80 | soy oil (KetoCal©) | 3 | > 8 | - | - | no significant differences in either tumor weight, survival or vascularity | [114] |
+ | + | + | Â | Â | Â | Â | Â | Â | Â | Â | Â |
BALB/cJ SCID mice | 14 | U87 glioblastoma | restricted to 65-70 E% of control | 3/17/80 | soy oil (KetoCal©) | 3 | >8 | ↓ b | ↓ b | 65% (CT-2A)band 35% (U87)cless tumor wet weight; |  |
 |  |  |  |  |  |  |  |  |  | longer survival b; lower number of blood vessels (both tumors) |  |
nu/nu mice | 20 | LNCaP human prostate cancer | ad libitum | 10/45/45 | ... | 14 | 63 | ↓ a | ... | plasma insulin levels ↓ c; plasma IGF1 levels ↓ c; | [97] |
 |  |  |  |  |  |  |  |  |  | 45% less tumor volume a; |  |
 |  |  |  |  |  |  |  |  |  | 43% less tumor dry weightc; |  |
 |  |  |  |  |  |  |  |  |  | decreased levels of phosphorylated Akt (below detected limits) and insulin receptor in tumor tissue |  |
SCID mice | 25 | LAPC-4 human prostate cancer | 9% more energy than control | 0/16/84 | milk fat + lard | -24 | > 40 | - | ↑ c | longer survival b | [134] |
NMRI mice | 12 | 23132/87 human gastric adenoma | ad libitum | 0/14/86 | cheese + MCT + omega-3 oil | 0 | > 16 | - | - | longer survival a; | [130] |
 |  |  |  |  |  |  |  |  |  | tumor growth rate ↓ c; |  |
 |  |  |  |  |  |  |  |  |  | larger necrotic area in tumors b |  |
C3H/HeN mice 4 | 5 | squamous cell car-cinoma VII | ad libitum | 16/58/26 | ... | -7 | 16 | ↑ | ↓ | 41% less tumor volume d | [131] |
Foxn1nu mice | 12 | LNT-229 glioma cells | ad libitum | 0/13/36 | flaxseed and hempseed oil | 1 | > 63 | - | - | no significant differences in survival, tumor growth and plasma IGF1 levels | [128] |